Breaking News Instant updates and real-time market news.

AVIR

Atea Pharmaceuticals

$59.98 /

-2.87 (-4.57%)

16:13
03/07/21
03/07
16:13
03/07/21
16:13

Atea Pharmaceuticals presents Phase 1 results for AT-527

Atea Pharmaceuticals presented results from the Phase 1 study of AT-527 in healthy volunteers at the 28th Annual Conference on Retroviruses and Opportunistic Infections in a Science Spotlight presentation. AT-527 is an orally administered, direct-acting antiviral developmental agent derived from Atea's purine nucleotide prodrug platform and is in Phase 2 clinical development for the treatment of COVID-19. AT-527 targets SARS-CoV-2 ribonucleic acid polymerase, a highly conserved gene which is responsible for both viral RNA replication and transcription. Given this preferential conserved target site, it is anticipated that the antiviral activity of AT-527 will continue even in the presence of naturally-evolving variants which are now emerging. In the Phase 1 study, 20 healthy volunteers were randomized 1:1 to receive oral AT-527 550 mg twice daily or matching placebo for 5 days. The purpose of this study was to assess the safety and pharmacokinetics of AT-527 in healthy volunteers and to predict human lung exposure of intracellular AT-9010, the active triphosphate metabolite of AT-527. Safety assessments included adverse events, vital signs, electrocardiograms, and standard safety laboratory tests. Intensive PK sampling, performed after the first and last two doses, provided information on plasma exposures of AT-511, the free base of AT-527, a hemisulfate salt, and its metabolites including AT-273, the guanosine nucleoside metabolite, a measurable surrogate for intracellular AT-9010. The study results showed AT-527 was well tolerated with a favorable safety profile. There were no discontinuations, serious AEs, clinically significant changes in vital signs, or ECGs observed. The data also demonstrated that AT-511 was rapidly absorbed, followed by fast and extensive stepwise metabolic activation ultimately to the intracellular TP metabolite AT-9010, reflected by plasma AT-273. AT-527 550 mg BID led to fast attainment of steady-state levels of AT-273 within two days of dosing. Plasma levels of AT-273 were further used to predict lung concentrations of AT-9010 using a scaling factor of 1.2X which was previously determined from in vivo tissue distribution of the triphosphate metabolite in cynomolgus monkeys. Beginning as early as three hours after the first dose, and maintained thereafter throughout the five days of dosing, predicted lung AT-9010 levels were consistently above the EC90 level of 0.5 microM for in vitro inhibition by the drug of SARS-CoV-2 replication. These results indicate the potential of AT-527 for the treatment of COVID-19 and are supportive of the dosing regimen of 550 mg BID.

  • 30

    Oct

AVIR Atea Pharmaceuticals
$59.98 /

-2.87 (-4.57%)

01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
11/24/20 JPMorgan
Atea Pharmaceuticals initiated with an Overweight at JPMorgan

TODAY'S FREE FLY STORIES

Recommendations
Correction: Occidental Petroleum remains Peer Perform at Wolfe Research » 09:29
04/12/21
04/12
09:29
04/12/21
09:29
OXY

Occidental Petroleum

$24.59 /

-0.14 (-0.57%)

Wolfe Research did not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OXY Occidental Petroleum
$24.59 /

-0.14 (-0.57%)

OXY Occidental Petroleum
$24.59 /

-0.14 (-0.57%)

04/01/21 Piper Sandler
Occidental Petroleum price target raised to $30 from $21 at Piper Sandler
03/23/21 Goldman Sachs
Occidental Petroleum assumed with a Neutral at Goldman Sachs
03/11/21 Wolfe Research
Occidental Petroleum upgraded to Peer Perform at Wolfe Research
03/11/21 Wolfe Research
Correction: Occidental Petroleum upgraded to Peer Perform at Wolfe Research
OXY Occidental Petroleum
$24.59 /

-0.14 (-0.57%)

OXY Occidental Petroleum
$24.59 /

-0.14 (-0.57%)

OXY Occidental Petroleum
$24.59 /

-0.14 (-0.57%)

OXY Occidental Petroleum
$24.59 /

-0.14 (-0.57%)

Recommendations
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming » 09:28
04/12/21
04/12
09:28
04/12/21
09:28
REGN

Regeneron

$475.52 /

-0.61 (-0.13%)

, LLY

Eli Lilly

$184.47 /

+1.87 (+1.02%)

Benchmark analyst Aydin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$475.52 /

-0.61 (-0.13%)

LLY Eli Lilly
$184.47 /

+1.87 (+1.02%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

03/24/21 Canaccord
Regeneron trial shows positive results against COVID-variants, says Canaccord
03/23/21 Piper Sandler
Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler
03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
LLY Eli Lilly
$184.47 /

+1.87 (+1.02%)

04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
03/16/21 Mizuho
Mizuho sees 'good reasons to be optimistic' on Lilly's donanemab
REGN Regeneron
$475.52 /

-0.61 (-0.13%)

LLY Eli Lilly
$184.47 /

+1.87 (+1.02%)

  • 27
    May
REGN Regeneron
$475.52 /

-0.61 (-0.13%)

LLY Eli Lilly
$184.47 /

+1.87 (+1.02%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

LLY Eli Lilly
$184.47 /

+1.87 (+1.02%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

LLY Eli Lilly
$184.47 /

+1.87 (+1.02%)

Conference/Events
Cowen energy analysts to hold an analyst/industry conference call » 09:25
04/12/21
04/12
09:25
04/12/21
09:25

Energy Analysts Osborne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Zai Lab participates in a conference call with JPMorgan » 09:25
04/12/21
04/12
09:25
04/12/21
09:25
ZLAB

Zai Lab

$132.84 /

-0.17 (-0.13%)

SMid Cap Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 5 minutes

Get Free Trial

ShowHide Related Items >><<
ZLAB Zai Lab
$132.84 /

-0.17 (-0.13%)

ZLAB Zai Lab
$132.84 /

-0.17 (-0.13%)

02/08/21 Jefferies
Zai Lab price target raised to $225 upon assumption at Jefferies
01/15/21 Citi
Citi boosts Zai Lab target to $216, adds to U.S. Focus List
01/07/21 Wedbush
Argenx price target raised to $293 from $283 at Wedbush
11/16/20 JPMorgan
Zai Lab price target raised to $111 from $101 at JPMorgan
ZLAB Zai Lab
$132.84 /

-0.17 (-0.13%)

Conference/Events
Cowen retail/consumer analysts to hold an analyst/industry conference call » 09:25
04/12/21
04/12
09:25
04/12/21
09:25

Retail & Consumer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
XPeng to debut new LiDAR-equipped smart EV XPeng P5 sedan » 09:24
04/12/21
04/12
09:24
04/12/21
09:24
XPEV

XPeng

$34.53 /

-0.9 (-2.54%)

Chinese smart EV company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

03/22/21 Deutsche Bank
XPeng confident about near-term demand trajectory, says Deutsche Bank
03/10/21 Citi
Xpeng price target lowered to $50 from $57.71 at Citi
03/09/21 Daiwa
Xpeng upgraded to Buy from Sell at Daiwa
03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

  • 09
    Dec
  • 27
    Aug
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

Hot Stocks
XPeng to debut new LiDAR-equipped smart EV XPeng P5 sedan » 09:24
04/12/21
04/12
09:24
04/12/21
09:24
XPEV

XPeng

$34.53 /

-0.9 (-2.54%)

Chinese smart EV company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

03/22/21 Deutsche Bank
XPeng confident about near-term demand trajectory, says Deutsche Bank
03/10/21 Citi
Xpeng price target lowered to $50 from $57.71 at Citi
03/09/21 Daiwa
Xpeng upgraded to Buy from Sell at Daiwa
03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

  • 09
    Dec
  • 27
    Aug
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

Conference/Events
FDA PDUFA Date for Avenue Therapeutics for IV Tramadol is April 12, 2021  09:23
04/12/21
04/12
09:23
04/12/21
09:23
ATXI

Avenue Therapeutics

$6.85 /

+0.17 (+2.54%)

 
ShowHide Related Items >><<
ATXI Avenue Therapeutics
$6.85 /

+0.17 (+2.54%)

ATXI Avenue Therapeutics
$6.85 /

+0.17 (+2.54%)

03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
ATXI Avenue Therapeutics
$6.85 /

+0.17 (+2.54%)

Conference/Events
Thryv Holdings participates in a conference call hosted by Cowen » 09:23
04/12/21
04/12
09:23
04/12/21
09:23
THRY

Thryv Holdings

$23.52 /

-0.48 (-2.00%)

Cowen holds a conference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THRY Thryv Holdings
$23.52 /

-0.48 (-2.00%)

THRY Thryv Holdings
$23.52 /

-0.48 (-2.00%)

11/17/20 William Blair
Thryv Holdings initiated with an Outperform at William Blair
THRY Thryv Holdings
$23.52 /

-0.48 (-2.00%)

Conference/Events
Nvidia to hold a virtual conference » 09:22
04/12/21
04/12
09:22
04/12/21
09:22
ADBE

Adobe

$504.01 /

+4.15 (+0.83%)

, AMZN

Amazon.com

$3,371.40 /

+73.69 (+2.23%)

, BABA

Alibaba

$223.35 /

-4.9 (-2.15%)

, BAYRY

Bayer

$15.92 /

-0.015 (-0.09%)

, C

Citi

$72.42 /

+0.12 (+0.17%)

, CRM

Salesforce

$231.28 /

+6.84 (+3.05%)

, FB

Facebook

$312.24 /

-0.93 (-0.30%)

, GOOG

Alphabet

$2,285.38 /

+20.38 (+0.90%)

, GOOGL

Alphabet Class A

$2,270.31 /

+20.25 (+0.90%)

, GRUB

GrubHub

$65.55 /

+0.11 (+0.17%)

, IBM

IBM

$135.73 /

+0.58 (+0.43%)

, MS

Morgan Stanley

$80.72 /

+0.53 (+0.66%)

, MSFT

Microsoft

$255.73 /

+2.37 (+0.94%)

, SPOT

Spotify

$279.50 /

-1.305 (-0.46%)

, VMW

VMware

$153.97 /

+1.45 (+0.95%)

, WMT

Walmart

$139.78 /

+0.08 (+0.06%)

, NVDA

Nvidia

$575.80 /

+3.46 (+0.60%)

Nvidia GTC-21 Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$504.01 /

+4.15 (+0.83%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BAYRY Bayer
$15.92 /

-0.015 (-0.09%)

C Citi
$72.42 /

+0.12 (+0.17%)

CRM Salesforce
$231.28 /

+6.84 (+3.05%)

FB Facebook
$312.24 /

-0.93 (-0.30%)

GOOG Alphabet
$2,285.38 /

+20.38 (+0.90%)

GOOGL Alphabet Class A
$2,270.31 /

+20.25 (+0.90%)

GRUB GrubHub
$65.55 /

+0.11 (+0.17%)

IBM IBM
$135.73 /

+0.58 (+0.43%)

MS Morgan Stanley
$80.72 /

+0.53 (+0.66%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

SPOT Spotify
$279.50 /

-1.305 (-0.46%)

VMW VMware
$153.97 /

+1.45 (+0.95%)

WMT Walmart
$139.78 /

+0.08 (+0.06%)

NVDA Nvidia
$575.80 /

+3.46 (+0.60%)

ADBE Adobe
$504.01 /

+4.15 (+0.83%)

04/08/21 BofA
BofA reinstates Adobe at Buy with $570 price target
04/08/21 BofA
Adobe reinstated with a Buy at BofA
03/24/21 BMO Capital
Adobe price target lowered to $535 from $570 at BMO Capital
03/24/21 Morgan Stanley
Adobe price target raised to $575 from $560 at Morgan Stanley
AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
04/05/21 Evercore ISI
Amazon.com assumed with an Outperform at Evercore ISI
04/01/21 Wedbush
Microsoft gets another major win within the beltway, says Wedbush
04/01/21 Credit Suisse
Ubiquiti price target lowered to $126 from $157 at Credit Suisse
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

08:37 Today Morgan Stanley
Alibaba named a Research Tactical Idea at Morgan Stanley
07:37 Today Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
06:41 Today Mizuho
Alibaba antitrust ruling 'removes overhang,' says Mizuho
06:37 Today Citi
Alibaba fine could help lift 'overhang' on shares, says Citi
BAYRY Bayer
$15.92 /

-0.015 (-0.09%)

03/19/21 Deutsche Bank
Bayer price target raised to EUR 66 from EUR 63 at Deutsche Bank
03/11/21 Societe Generale
Bayer price target lowered to EUR 59 from EUR 68 at Societe Generale
03/03/21 Berenberg
Bayer price target raised to EUR 68 from EUR 60 at Berenberg
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
C Citi
$72.42 /

+0.12 (+0.17%)

04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
04/05/21 Wolfe Research
Citi downgraded to Peer Perform at Wolfe Research amid 'valuation rethink'
CRM Salesforce
$231.28 /

+6.84 (+3.05%)

04/05/21 Credit Suisse
Salesforce assumed with an Outperform at Credit Suisse
03/24/21 Nord/LB
Salesforce downgraded to Hold from Buy at Nord/LB
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
03/15/21 Credit Suisse
Salesforce assumed with an Outperform at Credit Suisse
FB Facebook
$312.24 /

-0.93 (-0.30%)

04/05/21 Evercore ISI
Facebook assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Facebook initiated with an Outperform at Wolfe Research
03/29/21 Deutsche Bank
Facebook price target raised to $385 from $355 at Deutsche Bank
03/08/21 Jefferies
Facebook looks attractive following pullback, says Jefferies
GOOG Alphabet
$2,285.38 /

+20.38 (+0.90%)

04/05/21 Evercore ISI
Alphabet assumed with an Outperform at Evercore ISI
04/01/21 Morgan Stanley
Microsoft making progress toward being 'Netflix of Gaming,' says Morgan Stanley
03/31/21 Wolfe Research
Alphabet initiated with an Outperform at Wolfe Research
03/30/21
Fly Intel: Top five analyst upgrades
GOOGL Alphabet Class A
$2,270.31 /

+20.25 (+0.90%)

07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
04/09/21 Argus
Alphabet price target raised to $2,500 from $2,400 at Argus
04/05/21 Evercore ISI
Alphabet assumed with an Outperform at Evercore ISI
04/01/21 Morgan Stanley
Microsoft making progress toward being 'Netflix of Gaming,' says Morgan Stanley
GRUB GrubHub
$65.55 /

+0.11 (+0.17%)

01/04/21 Barclays
GrubHub assumed with an Equal Weight at Barclays
10/16/20 HSBC
HSBC upgrades Just Eat Takeaway.com to Buy on continued execution
08/28/20 Piper Sandler
Piper 'bearishly inclined' on Uber, Lyft shares into November election
08/13/20 DA Davidson
GrubHub price target raised to $79 from $63 at DA Davidson
IBM IBM
$135.73 /

+0.58 (+0.43%)

04/08/21 Morgan Stanley
IBM price target raised to $150 from $140 at Morgan Stanley
03/24/21 Evercore ISI
Intel price target raised to $75 from $68 at Evercore ISI
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
03/12/21 JMP Securities
Domo price target raised to $89 from $80 at JMP Securities
MS Morgan Stanley
$80.72 /

+0.53 (+0.66%)

04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
04/01/21 UBS
Morgan Stanley price target raised to $92 from $84 at UBS
MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

08:30 Today Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
SPOT Spotify
$279.50 /

-1.305 (-0.46%)

04/05/21 Evercore ISI
Spotify assumed with an Outperform at Evercore ISI
04/05/21
Fly Intel: Top five analyst upgrades
04/05/21 Citi
Spotify upgraded to Neutral from Sell at Citi
03/31/21 Wolfe Research
Spotify initiated with a Peer Perform at Wolfe Research
VMW VMware
$153.97 /

+1.45 (+0.95%)

04/08/21 BofA
VMware reinstated with a Neutral at BofA
04/08/21 BofA
VMware reinstated with a Neutral at BofA
03/15/21 Credit Suisse
VMware assumed with a Neutral at Credit Suisse
03/03/21 Citi
VMware assumed with a Buy at Citi
WMT Walmart
$139.78 /

+0.08 (+0.06%)

04/06/21 Morgan Stanley
Walmart+ membership 'seems to have stagnated,' says Morgan Stanley
03/16/21 MKM Partners
Walmart price target lowered to $141 from $154 at MKM Partners
02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
NVDA Nvidia
$575.80 /

+3.46 (+0.60%)

03/08/21 BofA
BofA says buy AMD and Nvidia as Steam data points to GPU upgrade tailwinds
03/02/21 Jefferies
Crypto miners not driving outsized gaming GPU revenues, says Jefferies
02/25/21 Craig-Hallum
Nvidia price target raised to $550 from $520 at Craig-Hallum
02/25/21 Needham
Nvidia price target raised to $800 from $700 at Needham
ADBE Adobe
$504.01 /

+4.15 (+0.83%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BAYRY Bayer
$15.92 /

-0.015 (-0.09%)

C Citi
$72.42 /

+0.12 (+0.17%)

CRM Salesforce
$231.28 /

+6.84 (+3.05%)

FB Facebook
$312.24 /

-0.93 (-0.30%)

GOOG Alphabet
$2,285.38 /

+20.38 (+0.90%)

GOOGL Alphabet Class A
$2,270.31 /

+20.25 (+0.90%)

GRUB GrubHub
$65.55 /

+0.11 (+0.17%)

IBM IBM
$135.73 /

+0.58 (+0.43%)

MS Morgan Stanley
$80.72 /

+0.53 (+0.66%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

SPOT Spotify
$279.50 /

-1.305 (-0.46%)

VMW VMware
$153.97 /

+1.45 (+0.95%)

WMT Walmart
$139.78 /

+0.08 (+0.06%)

NVDA Nvidia
$575.80 /

+3.46 (+0.60%)

ADBE Adobe
$504.01 /

+4.15 (+0.83%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BAYRY Bayer
$15.92 /

-0.015 (-0.09%)

C Citi
$72.42 /

+0.12 (+0.17%)

CRM Salesforce
$231.28 /

+6.84 (+3.05%)

FB Facebook
$312.24 /

-0.93 (-0.30%)

GOOG Alphabet
$2,285.38 /

+20.38 (+0.90%)

GOOGL Alphabet Class A
$2,270.31 /

+20.25 (+0.90%)

GRUB GrubHub
$65.55 /

+0.11 (+0.17%)

IBM IBM
$135.73 /

+0.58 (+0.43%)

MS Morgan Stanley
$80.72 /

+0.53 (+0.66%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

SPOT Spotify
$279.50 /

-1.305 (-0.46%)

VMW VMware
$153.97 /

+1.45 (+0.95%)

WMT Walmart
$139.78 /

+0.08 (+0.06%)

NVDA Nvidia
$575.80 /

+3.46 (+0.60%)

ADBE Adobe
$504.01 /

+4.15 (+0.83%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BAYRY Bayer
$15.92 /

-0.015 (-0.09%)

C Citi
$72.42 /

+0.12 (+0.17%)

CRM Salesforce
$231.28 /

+6.84 (+3.05%)

FB Facebook
$312.24 /

-0.93 (-0.30%)

GOOG Alphabet
$2,285.38 /

+20.38 (+0.90%)

GOOGL Alphabet Class A
$2,270.31 /

+20.25 (+0.90%)

GRUB GrubHub
$65.55 /

+0.11 (+0.17%)

IBM IBM
$135.73 /

+0.58 (+0.43%)

MS Morgan Stanley
$80.72 /

+0.53 (+0.66%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

SPOT Spotify
$279.50 /

-1.305 (-0.46%)

VMW VMware
$153.97 /

+1.45 (+0.95%)

WMT Walmart
$139.78 /

+0.08 (+0.06%)

NVDA Nvidia
$575.80 /

+3.46 (+0.60%)

ADBE Adobe
$504.01 /

+4.15 (+0.83%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

C Citi
$72.42 /

+0.12 (+0.17%)

CRM Salesforce
$231.28 /

+6.84 (+3.05%)

FB Facebook
$312.24 /

-0.93 (-0.30%)

GOOG Alphabet
$2,285.38 /

+20.38 (+0.90%)

GOOGL Alphabet Class A
$2,270.31 /

+20.25 (+0.90%)

IBM IBM
$135.73 /

+0.58 (+0.43%)

MS Morgan Stanley
$80.72 /

+0.53 (+0.66%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

SPOT Spotify
$279.50 /

-1.305 (-0.46%)

VMW VMware
$153.97 /

+1.45 (+0.95%)

WMT Walmart
$139.78 /

+0.08 (+0.06%)

NVDA Nvidia
$575.80 /

+3.46 (+0.60%)

Hot Stocks
XPeng to debut new LiDAR-equipped smart EV XPeng P5 sedan » 09:22
04/12/21
04/12
09:22
04/12/21
09:22
XPEV

XPeng

$34.53 /

-0.9 (-2.54%)

Chinese smart EV company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

03/22/21 Deutsche Bank
XPeng confident about near-term demand trajectory, says Deutsche Bank
03/10/21 Citi
Xpeng price target lowered to $50 from $57.71 at Citi
03/09/21 Daiwa
Xpeng upgraded to Buy from Sell at Daiwa
03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

  • 09
    Dec
  • 27
    Aug
XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

XPEV XPeng
$34.53 /

-0.9 (-2.54%)

Hot Stocks
Genius Brands greenlights season three of 'Rainbow Rangers' » 09:18
04/12/21
04/12
09:18
04/12/21
09:18
GNUS

Genius Brands

$1.77 /

-0.06 (-3.28%)

Genius Brands…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNUS Genius Brands
$1.77 /

-0.06 (-3.28%)

GNUS Genius Brands
$1.77 /

-0.06 (-3.28%)

Earnings
Zynex sees FY21 revenue $135M-$150M, consensus $138.03M » 09:18
04/12/21
04/12
09:18
04/12/21
09:18
ZYXI

Zynex

$15.66 /

+0.37 (+2.42%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley Securities
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley Securities
Zynex downgraded to Neutral from Buy at B. Riley Securities
01/29/21 Piper Sandler
Zynex downgraded to Neutral from Overweight at Piper Sandler
ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

  • 15
    Jul
ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

Options
Overnight activity included 1154 trades in SPX and 64 trades in VIX » 09:18
04/12/21
04/12
09:18
04/12/21
09:18
SPX

S&P 500

/

+

, VIX

Volatility Index S&P 500 Options

/

+

1154 trades were executed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
/

+

SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
VIX Volatility Index S&P 500 Options
/

+

SPX S&P 500
/

+

SPX S&P 500
/

+

SPX S&P 500
/

+

VIX Volatility Index S&P 500 Options
/

+

SPX S&P 500
/

+

Hot Stocks
Silver Bull postpones Annual Meeting of Shareholders » 09:17
04/12/21
04/12
09:17
04/12/21
09:17
SVBL

Silver Bull

/

+

Silver Bull Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SVBL Silver Bull
/

+

Earnings
Zynex backs Q1 revenue view $23M-$24.5M, consensus $23.82M » 09:17
04/12/21
04/12
09:17
04/12/21
09:17
ZYXI

Zynex

$15.66 /

+0.37 (+2.42%)

Backs Q1 Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley Securities
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley Securities
Zynex downgraded to Neutral from Buy at B. Riley Securities
01/29/21 Piper Sandler
Zynex downgraded to Neutral from Overweight at Piper Sandler
ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

  • 15
    Jul
ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

ZYXI Zynex
$15.66 /

+0.37 (+2.42%)

Hot Stocks
Wilhelmina shares jump after Retail ECommerce Ventures reports 18.4% stake » 09:16
04/12/21
04/12
09:16
04/12/21
09:16
WHLM

Wilhelmina

$5.27 /

-0.1 (-1.86%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WHLM Wilhelmina
$5.27 /

-0.1 (-1.86%)

Recommendations
Lowe's price target raised to $220 from $195 at Loop Capital » 09:14
04/12/21
04/12
09:14
04/12/21
09:14
LOW

Lowe's

$198.45 /

+4.26 (+2.19%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOW Lowe's
$198.45 /

+4.26 (+2.19%)

LOW Lowe's
$198.45 /

+4.26 (+2.19%)

03/29/21 Wells Fargo
Lowe's price target raised to $210 from $200 at Wells Fargo
03/09/21 Citi
Citi starts Best Buy with Sell, sees 'too many red flags'
03/08/21 Citi
Lowe's initiated with a Buy at Citi
02/25/21
Fly Intel: Top five analyst upgrades
LOW Lowe's
$198.45 /

+4.26 (+2.19%)

LOW Lowe's
$198.45 /

+4.26 (+2.19%)

LOW Lowe's
$198.45 /

+4.26 (+2.19%)

LOW Lowe's
$198.45 /

+4.26 (+2.19%)

Hot Stocks
Arcutis Biotherapeutics initiates Phase 3 trial of topical roflumilast cream » 09:14
04/12/21
04/12
09:14
04/12/21
09:14
ARQT

Arcutis Biotherapeutics

$26.56 /

-0.95 (-3.45%)

Arcutis Biotherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARQT Arcutis Biotherapeutics
$26.56 /

-0.95 (-3.45%)

ARQT Arcutis Biotherapeutics
$26.56 /

-0.95 (-3.45%)

02/02/21 Truist
Arcutis Biotherapeutics price target raised to $48 from $38 at Truist
02/01/21 Cowen
Arcutis Biotherapeutics price target raised to $80 from $55 at Cowen
01/28/21 JonesTrading
Arcutis Biotherapeutics initiated with a Buy at JonesTrading
11/09/20 Goldman Sachs
Arcutis Biotherapeutics upgraded to Buy from Neutral at Goldman Sachs
ARQT Arcutis Biotherapeutics
$26.56 /

-0.95 (-3.45%)

  • 03
    Feb
  • 02
    Oct
ARQT Arcutis Biotherapeutics
$26.56 /

-0.95 (-3.45%)

ARQT Arcutis Biotherapeutics
$26.56 /

-0.95 (-3.45%)

Recommendations
Home Depot price target raised to $350 from $310 at Loop Capital » 09:13
04/12/21
04/12
09:13
04/12/21
09:13
HD

Home Depot

$319.11 /

+4.54 (+1.44%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HD Home Depot
$319.11 /

+4.54 (+1.44%)

HD Home Depot
$319.11 /

+4.54 (+1.44%)

03/29/21 Wells Fargo
Home Depot price target raised to $330 from $310 at Wells Fargo
03/09/21 Citi
Citi starts Best Buy with Sell, sees 'too many red flags'
03/08/21 Citi
Home Depot initiated with a Buy at Citi
02/24/21 Morgan Stanley
Home Depot could be planning expenses conservatively, says Morgan Stanley
HD Home Depot
$319.11 /

+4.54 (+1.44%)

HD Home Depot
$319.11 /

+4.54 (+1.44%)

HD Home Depot
$319.11 /

+4.54 (+1.44%)

Hot Stocks
Genesco confirms receipt of Director nominations from Legion Partners » 09:13
04/12/21
04/12
09:13
04/12/21
09:13
GCO

Genesco

$48.52 /

+1.26 (+2.67%)

Genesco confirmed that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GCO Genesco
$48.52 /

+1.26 (+2.67%)

GCO Genesco
$48.52 /

+1.26 (+2.67%)

01/12/21 Pivotal Research
Genesco price target raised to $43 from $37 at Pivotal Research
01/11/21 CL King
Genesco's quarter-to-date comps ahead of estimates, says CL King
12/08/20 Jefferies
Deckers Brands price target raised to $346 from $315 at Jefferies
11/27/20 CL King
Genesco price target raised to $40 from $28 at CL King
GCO Genesco
$48.52 /

+1.26 (+2.67%)

Conference/Events
Needham to hold a virtual conference » 09:12
04/12/21
04/12
09:12
04/12/21
09:12
GRCL

Gracell

$13.52 /

-0.82 (-5.72%)

, LMAT

LeMaitre

$51.38 /

+0.82 (+1.62%)

, IONS

Ionis Pharmaceuticals

$42.32 /

-0.32 (-0.75%)

, TSHA

Taysha Gene Therapies

$21.35 /

+1.49 (+7.50%)

, ZEAL

Zealand Pharma

$33.60 /

+1.27 (+3.93%)

, CLSD

Clearside Biomedical

$2.66 /

+0.12 (+4.72%)

, MEIP

MEI Pharma

$3.43 /

+0.12 (+3.63%)

, PCVX

Vaxcyte

$20.27 /

-0.49 (-2.36%)

, EVLO

Evelo Biosciences

$10.03 /

+0.005 (+0.05%)

, IVC

Invacare

$8.23 /

-0.08 (-0.96%)

, BSGM

BioSig Technologies

$4.59 /

+0.12 (+2.68%)

, CYTK

Cytokinetics

$24.17 /

+0.01 (+0.04%)

, SYBX

Synlogic

$3.34 /

-0.02 (-0.60%)

, RNA

Avidity Biosciences

$22.12 /

-1.8 (-7.53%)

, CSTL

Castle Biosciences

$69.44 /

-1.2 (-1.70%)

, AGI

Alamos Gold

$8.37 /

+0.08 (+0.97%)

, CARA

Cara Therapeutics

$29.09 /

+1.645 (+5.99%)

, FIX

Comfort Systems USA

$79.11 /

+1.925 (+2.49%)

, ITRM

Iterum Therapeutics

$1.30 /

-0.305 (-19.00%)

, LTRN

Lantern Pharma

$17.05 /

-0.13 (-0.76%)

, OCGN

Ocugen

$6.96 /

+0.045 (+0.65%)

, QURE

uniQure

$33.77 /

-1.75 (-4.93%)

, STTK

Shattuck Labs

$28.31 /

+1.365 (+5.07%)

, VKTX

Viking Therapeutics

$5.93 /

-0.23 (-3.73%)

20th Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRCL Gracell
$13.52 /

-0.82 (-5.72%)

LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

IVC Invacare
$8.23 /

-0.08 (-0.96%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

02/03/21 Citi
Gracell initiated with a Buy at Citi
02/02/21 Jefferies
Gracell initiated with a Buy at Jefferies
02/02/21 Wells Fargo
Gracell initiated with an Overweight at Wells Fargo
02/02/21 Piper Sandler
Gracell initiated with an Overweight at Piper Sandler
LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

02/26/21 Barrington
LeMaitre price target raised to $49 from $47 at Barrington
02/12/21
Fly Intel: Top five analyst initiations
02/12/21 KeyBanc
LeMaitre initiated with a Sector Weight at KeyBanc
02/11/21 KeyBanc
LeMaitre initiated with a Sector Weight at KeyBanc
IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

03/04/21 Chardan
Taysha Gene Therapies price target raised to $60 from $45 at Chardan
02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

03/02/21 Roth Capital
Clearside enrollment speed 'encouraging,' says Roth Capital
12/03/20 Roth Capital
Clearside platform validated by Janssen deal, says Roth Capital
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/19/20 Roth Capital
Clearside Biomedical abstracts highlight strength, says Roth Capital
MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
05/29/20
Fly Intel: Top five analyst initiations
PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

07:52 Today Jefferies
Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum
04:50 Today Jefferies
Evelo Biosciences upgraded to Buy from Hold at Jefferies
03/12/21 Chardan
Evelo Biosciences price target raised to $15 from $10 at Chardan
01/25/21 JMP Securities
Evelo Biosciences price target raised to $36 from $27 at JMP Securities
IVC Invacare
$8.23 /

-0.08 (-0.96%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

03/25/21 SVB Leerink
Synlogic price target raised to $15 from $10 at SVB Leerink
03/18/21 JonesTrading
Synlogic initiated with a Buy at JonesTrading
01/13/21 Chardan
Chardan doubles Synlogic target to $10, names top 2021 pick
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

03/09/21 Baird
Castle Biosciences price target lowered to $82 from $87 at Baird
02/03/21 KeyBanc
Castle Biosciences price target raised to $90 from $70 at KeyBanc
01/26/21 Canaccord
Castle Biosciences price target raised to $84 from $80 at Canaccord
01/15/21 SVB Leerink
Castle Biosciences price target raised to $80 from $70 at SVB Leerink
AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

02/10/21 JPMorgan
Alamos Gold initiated with a Neutral at JPMorgan
02/08/21 CIBC
Alamos Gold price target lowered to C$16 from C$19.25 at CIBC
02/02/21 National Bank
Alamos Gold price target lowered to C$14.50 from C$15.50 at National Bank
01/11/21 National Bank
Alamos Gold price target lowered to C$15.50 from C$16 at National Bank
CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

12/29/20 H.C. Wainwright
H.C. Wainwright reiterates $33 target on Cara after new drug filing
10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

07/29/20 DA Davidson
Comfort Systems USA price target raised to $45 from $32 at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/20/20 Sidoti
Comfort Systems USA downgraded to Neutral from Buy at Sidoti
ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

03/15/21 H.C. Wainwright
Iterum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
12/24/20 H.C. Wainwright
Iterum CSO resignation 'somewhat troubling,' says H.C. Wainwright
06/16/20 H.C. Wainwright
Iterum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/02/20 RBC Capital
Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

08/10/20 ThinkEquity
Lantern Pharma initiated with a Buy at ThinkEquity
07/28/20 Colliers
Drug 'rescuer' Lantern Pharma started at Buy at Colliers
07/28/20 Colliers
Lantern Pharma initiated with a Buy at Colliers
OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

03/31/21
Ocugen participates in a conference call with Cantor Fitzgerald
03/16/21 Roth Capital
Covaxin chances of U.S. approval now increased, says Roth Capital
03/04/21 Roth Capital
Ocugen price target raised to $10 from $9 at Roth Capital
03/04/21 Roth Capital
Roth boosts Ocugen target after partnered vaccine shows 'broad' efficacy
QURE uniQure
$33.77 /

-1.75 (-4.93%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
04/01/21 Mizuho
uniQure upgraded to Buy from Neutral at Mizuho
03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

02/18/21 Chardan
Chardan trims Viking Therapeutics target to $19 as COVID pushes out Voyage data
09/11/20 B. Riley FBR
Viking Therapeutics price target raised to $15 from $12 at B. Riley FBR
09/01/20 BTIG
Viking Therapeutics price target raised to $12 from $9 at BTIG
08/30/20 Chardan
Viking Therapeutics price target raised to $20 from $15 at Chardan
LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

IVC Invacare
$8.23 /

-0.08 (-0.96%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

  • 29
    Jan
  • 15
    Jan
  • 08
    Jan
  • 16
    Dec
  • 09
    Oct
  • 24
    Sep
  • 17
    Jul
  • 25
    Jun
  • 25
    Jun
  • 12
    Jun
  • 12
    Jun
  • 11
    Jun
OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

Hot Stocks
Osisko Development announces drilling results from Cariboo drill program » 09:11
04/12/21
04/12
09:11
04/12/21
09:11
RNGTF

Osisko Development

$5.92 /

+0.008 (+0.14%)

Osisko Development is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNGTF Osisko Development
$5.92 /

+0.008 (+0.14%)

RNGTF Osisko Development
$5.92 /

+0.008 (+0.14%)

02/16/21 Canaccord
Osisko Development initiated with a Speculative Buy at Canaccord
01/11/21 National Bank
Osisko Development price target raised to C$11 from C$10.75 at National Bank
Hot Stocks
Navigator Holdings, Ultragas ApS to merge fleets, businesses » 09:11
04/12/21
04/12
09:11
04/12/21
09:11
NVGS

Navigator Holdings

$9.12 /

+0.12 (+1.33%)

Navigator Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVGS Navigator Holdings
$9.12 /

+0.12 (+1.33%)

NVGS Navigator Holdings
$9.12 /

+0.12 (+1.33%)

01/29/21 Jefferies
Navigator Holdings price target raised to $14 from $12 at Jefferies
01/27/21 Evercore ISI
Navigator Holdings downgraded to In Line from Outperform at Evercore ISI
01/27/21 Evercore ISI
Navigator Holdings downgraded to In Line from Outperform at Evercore ISI
NVGS Navigator Holdings
$9.12 /

+0.12 (+1.33%)

Hot Stocks
Senmiao Technology signs framework agreement with Taoyun Capital » 09:11
04/12/21
04/12
09:11
04/12/21
09:11
AIHS

Senmiao Technology

$1.41 /

-0.045 (-3.10%)

Senmiao Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIHS Senmiao Technology
$1.41 /

-0.045 (-3.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.